Hydroxylamine derivatives

Details for Australian Patent Application No. 2004299232 (hide)

Owner Newron Pharmaceuticals S.p.A. Vicuron Pharmaceuticals Inc.

Inventors Girola, Laura; Salvati, Patricia; Kaltofen, Petra Karin; Caccia, Carla; Thaler, Florian; Selva, Enrico; Losi, Daniele

Agent Lord and Company

Pub. Number AU-B-2004299232

PCT Pub. Number WO2005/058800

Priority 03028441.8 11.12.03 EP

Filing date 10 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 19 August 2010

International Classifications

C07C 239/12 (2006.01) Compounds containing nitrogen-to-halogen bonds

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07C 239/20 (2006.01) Compounds containing nitrogen-to-halogen bonds

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/058800 Priority application(s): WO2005/058800

19 August 2010 Application Accepted

  Published as AU-B-2004299232

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004299235-Novel herbicides

2004299231-Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of Alzheimer's disease